Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 130.80 INR
Change Today +1.75 / 1.36%
Volume 3.7K
PNCB On Other Exchanges
Symbol
Exchange
Natl India
As of 1:08 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

panacea biotec ltd (PNCB) Snapshot

Open
125.10
Previous Close
129.05
Day High
131.00
Day Low
125.10
52 Week High
09/22/14 - 219.35
52 Week Low
03/27/15 - 98.60
Market Cap
8.0B
Average Volume 10 Days
39.4K
EPS TTM
-17.37
Shares Outstanding
61.3M
EX-Date
09/19/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PANACEA BIOTEC LTD (PNCB)

Related News

No related news articles were found.

panacea biotec ltd (PNCB) Related Businessweek News

No Related Businessweek News Found

panacea biotec ltd (PNCB) Details

Panacea Biotec Limited, a health management company, researches and develops, manufactures, and markets pharmaceuticals, biopharmaceuticals, vaccines, and natural/indigenous products in India and internationally. Its product portfolio includes prescription products in various therapeutic areas, including pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care and vaccines. The company has collaboration agreements with The Institute for Translational Vaccinology (Intravacc), the Netherlands; JSC Binnopharm Inc., Russia; National Institute of Immunology, India; Dr. Reddy’s Laboratories Limited; PT BioFarma, Indonesia; and Kremers Urban Inc., as well as strategic alliance with Apotex Inc. Panacea Biotec Limited was founded in 1984 and is based in New Delhi, India.

Founded in 1984

panacea biotec ltd (PNCB) Top Compensated Officers

Managing Director, Director and Member of Sta...
Total Annual Compensation: 7.2M
Joint Managing Director and Whole-Time Direct...
Total Annual Compensation: 6.0M
Joint Managing Director and Director
Total Annual Compensation: 5.6M
Founder and Chairman
Total Annual Compensation: 7.2M
Director of Operations & Projects, Whole-Time...
Total Annual Compensation: 2.5M
Compensation as of Fiscal Year 2014.

panacea biotec ltd (PNCB) Key Developments

Panacea Biotec Ltd. Announces Audited Standalone Earnings Results for the Fourth Quarter and Year Ended and Audited Consolidated Earnings Results for the Year Ended March 31, 2015

Panacea Biotec Ltd. announced audited standalone earnings results for the fourth quarter and year ended and audited consolidated earnings results for the year ended March 31, 2015. For the quarter, on standalone basis, the company's net sales/income from operations was INR 2,179.5 million compared with INR 1,561.5 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 20.0 million compared with INR 594.5 million a year ago. Loss from ordinary activities before tax was INR 295.0 million compared with profit from ordinary activities before tax of INR 339.8 million a year ago. Net loss for the period was INR 313.9 million or INR 5.12 per basic and diluted share compared with net profit for the period of INR 339.8 million or INR 5.55 per basic and diluted share a year ago. For the year, on standalone basis, the company's net sales/income from operations was INR 6,432.4 million compared with INR 4,671.4 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 5.7 million compared with loss from operations before other income, finance costs and exceptional items of INR 1,632.9 million a year ago. Loss from ordinary activities before tax was INR 633.4 million compared with INR 4.2 million a year ago. Net loss for the period was INR 652.3 million or INR 10.64 per basic and diluted share compared with INR 24.2 million or INR 0.07 per basic and diluted share a year ago. For the year, on consolidated basis, the company's net sales/income from operations was INR 6,511.9 million compared with INR 4,795.6 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 245.7 million compared with INR 1,500.0 million a year ago. Loss from ordinary activities before tax was INR 994.0 million compared with INR 1,109.6 million a year ago. Net loss for the period was INR 1,024.7 million or INR 17.37 per basic and diluted share compared with INR 1,126.4 million or INR 18.29 per basic and diluted share a year ago.

Panacea Biotec Ltd Announces Executive Changes, with Effect from May 29, 2015

Panacea Biotec Ltd. has reported that the Board of Directors of the company at its meeting held on May 28, 2015, had approved the appointment of Mr. Devender Gupta, who is currently working as G.M. Finance & Strategic Management, as Chief Financial Officer (CFO) as a Key Managerial Personnel of the Company in terms of Section 203 of the Companies Act, 2013 with effect from May 29, 2015. Further, Mr. Vinod Goel currently working as Sr. V.P. Legal & Company Secretary has been designated as Group CFO & Company Secretary with effect from May 29, 2015. The said appointments were made on the recommendation and approval of Audit Committee and Nomination & Remuneration Committee of the Board of Directors of the Company.

Panacea Biotec Ltd. to Report Fiscal Year 2015 Results on May 28, 2015

Panacea Biotec Ltd. announced that they will report fiscal year 2015 results on May 28, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PNCB:IN 130.80 INR +1.75

PNCB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GlaxoSmithKline PLC 1,348 GBp -7.50
Johnson & Johnson $98.44 USD -0.03
Novartis AG SFr.93.05 CHF -0.85
Pfizer Ltd/India 1,988 INR +7.70
Sanofi India Ltd 3,580 INR +13.25
View Industry Companies
 

Industry Analysis

PNCB

Industry Average

Valuation PNCB Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PANACEA BIOTEC LTD, please visit www.panacea-biotec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.